Mani, Inc.
Mani, Inc. engages in the manufacture and supply of surgical and dental instruments in Japan, Asia, Europe, North America, and internationally. The company operates through three segments: Surgical Products, Eyeless Needle Products, and Dental Products. The company offers surgical instruments, such as maniplers, vessel knives, ENT knives, and stainless wire needles; and ophthalmic instruments, in… Read more
Mani, Inc. (MNICF) - Net Assets
Latest net assets as of August 2025: $53.56 Billion USD
Based on the latest financial reports, Mani, Inc. (MNICF) has net assets worth $53.56 Billion USD as of August 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($57.99 Billion) and total liabilities ($4.43 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $53.56 Billion |
| % of Total Assets | 92.37% |
| Annual Growth Rate | 7.93% |
| 5-Year Change | 36.63% |
| 10-Year Change | N/A |
| Growth Volatility | 4.6 |
Mani, Inc. - Net Assets Trend (2020–2025)
This chart illustrates how Mani, Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Mani, Inc. (2020–2025)
The table below shows the annual net assets of Mani, Inc. from 2020 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-08-31 | $53.56 Billion | +2.35% |
| 2024-08-31 | $52.33 Billion | +5.03% |
| 2023-08-31 | $49.83 Billion | +9.72% |
| 2022-08-31 | $45.41 Billion | +15.85% |
| 2021-08-31 | $39.20 Billion | +7.21% |
| 2020-08-31 | $36.56 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Mani, Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 30.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (August 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $48.92 Billion | 91.34% |
| Other Components | $4.64 Billion | 8.66% |
| Total Equity | $53.56 Billion | 100.00% |
Mani, Inc. Competitors by Market Cap
The table below lists competitors of Mani, Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Xinjiang Communications Construction Group Co Ltd Class A
SHE:002941
|
$839.14 Million |
|
Phoenix Silicon International Corp
TW:8028
|
$839.14 Million |
|
Clear Channel Outdoor Holdings Inc
NYSE:CCO
|
$839.28 Million |
|
Megmilk Snow Brand Co. Ltd
F:6MG
|
$839.43 Million |
|
Protector Forsikring ASA
OTCGREY:PSKRF
|
$838.66 Million |
|
NCR Corp.
LSE:0K45
|
$838.30 Million |
|
CARGOJET INC. VAR VTG
F:CJ8A
|
$838.16 Million |
|
LifeTech Scientific Corporation
PINK:LFTSF
|
$838.16 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Mani, Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 52,330,000,000 to 53,561,000,000, a change of 1,231,000,000 (2.4%).
- Net income of 4,643,000,000 contributed positively to equity growth.
- Dividend payments of 3,840,000,000 reduced retained earnings.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $4.64 Billion | +8.67% |
| Dividends Paid | $3.84 Billion | -7.17% |
| Other Changes | $428.00 Million | +0.8% |
| Total Change | $- | 2.35% |
Book Value vs Market Value Analysis
This analysis compares Mani, Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.02x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-08-31 | $371.50 | $12.82 | x |
| 2021-08-31 | $398.28 | $12.82 | x |
| 2022-08-31 | $461.39 | $12.82 | x |
| 2023-08-31 | $505.86 | $12.82 | x |
| 2024-08-31 | $531.17 | $12.82 | x |
| 2025-08-31 | $543.75 | $12.82 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Mani, Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.67%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 15.49%
- • Asset Turnover: 0.52x
- • Equity Multiplier: 1.08x
- Recent ROE (8.67%) is below the historical average (10.72%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 9.10% | 21.90% | 0.39x | 1.07x | $-327.50 Million |
| 2021 | 10.95% | 24.96% | 0.40x | 1.09x | $370.90 Million |
| 2022 | 11.65% | 25.91% | 0.41x | 1.10x | $748.70 Million |
| 2023 | 11.95% | 24.31% | 0.45x | 1.10x | $970.40 Million |
| 2024 | 12.01% | 22.05% | 0.50x | 1.09x | $1.05 Billion |
| 2025 | 8.67% | 15.49% | 0.52x | 1.08x | $-713.10 Million |
Industry Comparison
This section compares Mani, Inc.'s net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,683,526,542
- Average return on equity (ROE) among peers: -32.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Mani, Inc. (MNICF) | $53.56 Billion | 9.10% | 0.08x | $838.72 Million |
| ANGELALIGN TECHNOLOGY INC (AGLFF) | $480.24 Million | 2.52% | 0.41x | $405.57 Million |
| Akoya Biosciences Inc (AKYA) | $-30.16 Million | 0.00% | 0.00x | $16.24 Million |
| Alcon AG (ALC) | $19.68 Billion | 1.70% | 0.48x | $37.82 Billion |
| Align Technology Inc (ALGN) | $3.85 Billion | 10.94% | 0.61x | $11.75 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $354.40 Million |
| Ansell Limited (ANSLF) | $386.33 Million | -0.45% | 0.87x | $2.58 Billion |
| AptarGroup Inc (ATR) | $2.07 Billion | 11.57% | 1.03x | $8.27 Billion |
| AtriCure Inc (ATRC) | $72.60 Million | -15.79% | 0.54x | $1.42 Billion |
| Avinger Inc (AVGR) | $-35.69 Million | 0.00% | 0.00x | $1.26 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $9.03 Million | -338.35% | 0.77x | $156.14 Million |